Patents & Intellectual Properties From Dr. Muhammed Majeed
Patents & Intellectual Properties
Innovation recognized by the world
| Sl. No. | Title | Patent No | Brand /Ingredient |
|---|---|---|---|
| Compositions for Management of Polycystic Ovary Syndrome | US 12,233,032 | Curcumin BD3 Complex | |
| Compositions for management of acute nephrotoxicity | US 12,053,500 | Curucmin BD3 Complex | |
| Method of isolating secondary metabolites from cambium derived callus cultures | US 12,022,786 | Callus culture | |
| Compositions for targeting receptor for advanced glycation end-products (rage) in a chronic inflammatory condition | US 11,957,728 | Curcumin BD3 Complex | |
| Process and compositions for enhancing energy expenditure | US 11, 925, 671 | Cirpusins® | |
| Compositions for managing chronic obstructive pulmonary disease | US 11, 925, 606 | Curcumin BD3 Complex | |
| Skin care applications of extracellular metabolites from Bacillus coagulans | US 11, 865, 203 | LactoSporin® | |
| Therapeutic compositions and methods for pulmonary fibrosis | US 11, 744, 807 | Isogarcinol+ Octohydrocurcumin |
|
| Curcuminoid composition for therapeutic management of metabolic syndrome | US 11, 707, 438 | C3 Reduct® Special | |
| Curcuminoid composition and its therapuetic potential in managing lung fibrosis | US 11, 491, 119 | C3 Reduct® Special | |
| Compositions and methods for beta secretase inhibition | US 11, 458, 117 | Sabroxy® | |
| Method and composition for therapeutic management of gluten intolerance | US 11, 419, 906 | LactoSpore® | |
| Compositions and methods for management of atrophic gastritis and colitis | US 11, 413, 318 | LactoSpore® | |
| Plant actives and their anti-pollution effects thereof | US 11, 351, 102 | Sabroxy®+(THC / Pterostilbene / Resvenox®) | |
| Alcoholic beverage composition containing Bacillus coagulans | US 11, 332, 702 | LactoSpore® | |
| Microbial bioconversion of curcuminoids to Calebin-A | US 11, 299, 706 | CurCousin® | |
| Isolates from spent turmeric for the management of rheumatoid arthritis | US 11, 298, 395 | Starmeric® | |
| Modulation of immune function by Bacillus coagulans | US 11, 298, 381 | Immunospore™ | |
| Hypolipidemic effects of Bacillus coagulans | US 11, 213, 553 | LactoSpore® | |
| Stable probiotic composition for the management of lactose intolerance | US 11, 202, 810 | LactoSpore® | |
| Fructophilic lactic acid producing bacteria | US 11, 197, 898 | Fructospore | |
| Hair care compositions containing extracellular metabolite preparation from Bacillus coagulans | US 11, 123, 382 | LactoSporin® | |
| Beverage compositions containing Bacillus coagulans MTCC 5856 | US 11, 052, 125 | LactoSpore® | |
| Compositions for weight loss | US 11, 052, 125 | Cyperus+Forskolin+Garcinol | |
| Composition for the therapeutic management of hypomelanotic skin conditions | US 11, 045, 517 | Forskolin+Nigellin® | |
| Anti-aging potential of extracellular metabolite isolated from Bacillus coagulansMTCC 5856 | US 10, 966, 919 | LactoSporin® | |
| Bioactive molecules from Oroxylum indicumand their therapeutic applications | US 10, 959, 980 | Sabroxy® | |
| Compositions containing thymohydroquinone and their method of preparation | US 10, 945, 969 | Nigellin® | |
| Method of inhibiting propionibacterium acnes | US 10, 898, 536 | Artocarpus | |
| Neuroprotective compositions and their use | US 10, 894, 029 | Sabroxy® | |
| Compositions for the management of hyperglycemia and related conditions | US 10, 881, 623 | Nigellin® | |
| Composition for prostaglandin transporter inhibition and related therapeutic applications | US 10, 864, 243 | Sabeet®+Nigellin®+Arjuna+SelenoForce® | |
| Aphrodisiac composition and management of male sexual dysfunction | US 10, 864, 242 | Xxtrastrong | |
| Skin care compositions and their applications | US 10, 864, 154 | Ethyl ascorbic acid + THC | |
| Compositions and methods for reducing flatulence | US 10, 806, 760 | LactoSpore® | |
| Composition for management of Helicobacter pyloriinfection | US 10, 792, 295 | LactoSpore®+Saberry® | |
| Adaptogenic compositions and applications thereof | US 10, 716, 823 | Polybos + Saberry® Polybos+Cococin™ |
|
| Stable probiotic composition containing Bacillus coagulansMTCC 5856 and method of detection thereof | US 10, 668, 115 | LactoSpore® | |
| Liver protectant compositions and therapeutic applications | US 10, 653, 643 | LivLonga® | |
| Beverage compositions containing Bacillus coagulansMTCC 5856 | US 10, 609, 935 | LactoSpore® | |
| Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | US 10, 588, 844 | Oletrip | |
| Composition containing Oroxylin A and method of extraction thereof | US 10, 555, 982 | Oroxylin | |
| Telomerase enhancement potential of Ecdysterone | US 10, 548, 902 | Ecdysterone | |
| Functional nutritional blend for thermo-metabolic performance | US 10, 477, 886 | Metabolicgard | |
| Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna | US 10, 479, 749 | Arjunoglucoside | |
| Process for the preparation of enantiopure 3-amino tetrahydrofuran and its salts | US 10, 421, 734 | 3-Amino Tetrahydrofurans | |
| Process for synthesis of Oroxylin A | US 10, 407, 401 | Sabroxy® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | US 10, 323, 227 | LactoSpore®+Starmeric™ | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | US 10, 293, 008 | LactoSpore® | |
| Novel PCR primers and methods thereof for the identification of Bacillus coagulansMTCC 5856 | US 10, 260, 112 | LactoSpore® | |
| Functional nutritional blend for thermo-metabolic performance | US 10, 258, 073 | Metabolicgard | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | US 10, 172, 903 | Cyperus | |
| Bacillus coagulansMTCC 5856 for the management of major depressive disorder | US 10, 166, 261 | LactoSpore® | |
| Process and compositions for achieving mammalian energy balance | US 10, 085, 963 | Forskolin | |
| Oleanoyl peptide composition and skin hydration | US 10, 071, 043 | Olepent® | |
| Anti-cancer activity of (E)-1-(3′, 4′-Dimethoxyphenyl) butadiene | US 9, 913, 809 | Zingiber cassumnar | |
| Anti-cancer activity of (E)-1-(3′, 4′-Dimethoxyphenyl) butadiene | US 9, 833, 422 | Zingiber cassumnar | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | US 9, 782, 450 | Cyperus | |
| Calebin A for hepatic steatosis | US 9, 737, 502 | CurCousin® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | US 9, 717, 766 | LactoSpore®+LactoCran™ | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulansand biological applications thereof | US 9, 681, 666 | LactoSporin®+SabiLize® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulansand biological applications thereof | US 9, 681, 665 | LactoSporin® | |
| Method for the treatment of hypercholesterolemia | US 9, 668, 999 | CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulansand biological applications thereof | US 9, 635, 862 | LactoSporin®, LactoSporin®+Sabilize® | |
| Method for the treatment of hypercholesterolemia | US 9, 610, 273 | CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulansand biological applications thereof | US 9, 596, 861 | LactoSporin® | |
| Process for the therapeutic management of Diarrhea predominant irritable bowel syndrome using Bacillus coagulans | US 9, 579, 352 | LactoSpore® | |
| Calebin A for osteoporosis | US 9, 539, 232 | CurCousin® | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | US 9, 498, 423 | Saberry®+Cococin™+Se Peptide | |
| Process for the manufacture of 3′-hydroxy pterostilbene | US 9, 458, 075 | 3-hydroxypterostilbene | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | US 9, 387, 193 | Cyperus | |
| Synthesis of Calebin A and its biologically active analogs | US 9, 365, 486 | CurCousin® | |
| Anti-obesity potential of Calebin A | US 9, 328, 330 | CurCousin® | |
| Composition and method for the protection of articular cartilage | US 9, 220, 703 | CurCousin® | |
| Orally bioavailable stilbenoids-compositions and therapeutic applications thereof | US 9, 056, 074 | 3-hydroxypterostilbene | |
| Orally bioavailable stilbenoids-compositions and therapeutic applications thereof | US 9, 050, 284 | 3-hydroxypterostilbene | |
| Synthesis of 4-aryl 4-acyl piperidine, its salts and analogs using indium metal | US 9, 029, 547 | Pharmaceutical Intermediates | |
| Orally bioavailable stilbenoids-compositions and therapeutic applications thereof | US 9, 029, 424 | 3-hydroxypterostilbene | |
| Oleanoyl peptide composition and method of treating skin aging | US 8, 987, 212 | Olepent® | |
| Anti-obesity potential of Calebin A | US 8, 933, 121 | CurCousin® | |
| Novel synthesis of 4-aryl 4-acyl piperidine, its salts and analogs using indium metal | US 8, 853, 407 | Pharmaceutical intermediates | |
| Inotilone derivatives as coherent biological response modifier (cBMR) | US 8, 394, 852 | Inotilone derivatives | |
| Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals | US 8, 383, 594 | Olepent® | |
| Compositions and its use in treating obesity or inducing weight loss | US 8, 329, 743 | Livinol™+Pterostilbene+Anthocyanin | |
| Preservative system for cosmetic formulations—compositions and methods thereof | US 8, 329, 095 | SabiLize® | |
| Protective compositions for dermal papilla cells | US 8, 247, 003 | Saberry®+Cococin™ | |
| Dipeptides incorporating selenoamino acids with enhanced bioavailability–synthesis, pharmaceutical and cosmeceutical applications thereof | US 8, 193, 156 | LSM-Dipeptide Synthetic route | |
| Treatment of superficial and cutaneous mycoses with a pure form of 1, 7-bis(4-hydroxy-3-methoxyphe nyl)-3, 5-heptanedione | US 8, 119, 696 | TetraPure® | |
| Dipeptides incorporating selenoaminoacids with enhanced bioavailability-synthesis | US 8, 003, 614 | MSC-Dipeptide Synthetic route | |
| Hydro-alkoxyl citronellal compounds – synthetic routes, compositions and uses thereof | US 7, 842, 842 | Woody Odorants | |
| Composition and methods for the management of hyperproliferative dermatological conditions | US 7, 582, 314 | Boswellin® | |
| Novel non-cytotoxic synthetic analogues of (1E, 6E)-1, 7-Bis (4 hydroxy-3-methoxyphenyl)-1, 6-heptadiene-3, 5-dione and therapeutic applications thereof in cystic fibrosis | US 7, 521, 580 | Curcuminoid analogs | |
| Processes for the manufacture of chiral and racemic forms of 3-aminotetrahydrofurans, their salts and derivatives | US 7, 514, 573 | 3-Aminotetrahydrofurans | |
| Convenient process of manufacture for Difluoromethylornithine and related compounds | US 7, 345, 196 | Efflornithine | |
| Method of preparation and use of coconut water in mamalian tissue nourishment growth and healthy maintenance | US 7, 300, 682 | Cococin™ | |
| Process for the synthesis of biologically active oxygenated compounds by dealkylation of the corresponding alkylethers | US 7, 253, 324 | Stilbenes | |
| Commercially viable process for high purity of fatty alcohol C24 to C36 and its cosmetic application for skin hair and nails | US 7, 217, 546 | Policosanol | |
| Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: Process for their manufacture and Uses | US 7, 202, 270 | Liposol® | |
| Bioavailable composition of natural and synthetic HCA | US 7, 063, 861 | GarCitrin® | |
| Compositions and methods containing Allium sativumLinn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation | US 7, 014, 874 | SelenoForce® | |
| Convenient process of manufacture for Difluoromethylornithine and related compounds | US 6, 998, 502 | Efflornithine | |
| Compositions and methods containing bioavailable Se-methyl-L-selenocysteine for human and veterinary use | US 6, 982, 273 | Methyselene®(MSC) | |
| Process for preparing water soluble diterpenes and their applications | US 6, 960, 300 | Ocufors® | |
| Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | US 6, 849, 645 | Cosmoperine® (THP) | |
| Manufacturing processes for Se-methyl-selenocysteine | US 6, 794, 537 | Methyselene®(MSC) | |
| Process of obtaining compositions of stable lutein and lutein derivatives | US 6, 689, 400 | ZeaLutein® | |
| Composition and methods containing an antimicrobial essential oil extracted from Coleus forskohlii | US 6, 607, 712 | Coleus Oil | |
| Composition and method containing products extracted from commiphorasp. for prevention and treatment of abnormal cell growth and proliferation in inflammation, neoplasia and cardiovascular disease | US 6, 436, 991 | Gugulipid® | |
| New Chemical entities with multiple modes of anti-inflammatory action | US 7, 378, 442 | AKBBA+NSAIDS | |
| New chemical entities with multiple modes of anti-inflammatory action | US 7, 371, 889 | AKBBA+NSAIDS | |
| Compositions and methods containing natural compounds from nonconventional sources that are useful in maintaining normal blood sugar levels | US 7, 160, 562 | Metformin-like compounds | |
| Process for the production of potassium hydroxy citric acid, and compositions containing the potassium hydroxy citric acid | US 6, 770, 782 | Citrin®K | |
| Cross regulin composition of turmeric-derived Tetrahydrocurcuminoids for skin lightening and protection against UVB rays | US 6, 653, 327 | Tetrahydrocurcuminoids | |
| Process for making high purity piperine for nutritional use | US 6, 054, 585 | BioPerine® | |
| Use of piperine as a bioavailability enhancer | US 5, 972, 382 | BioPerine® | |
| Bioprotectant composition, method of use and extraction process of curcuminoids | US 5, 861, 415 | Curcumin C3 Complex® | |
| Method of preparing a forskolin composition from forskolin extract and use of forskolin for promoting lean body mass and treating mood disorders | US 5, 804, 596 | ForsLean® | |
| Potassium hydroxycitrate for the suppression of appetite and induction of weight loss | US 5, 783, 603 | Citrin® K | |
| Use of piperine as a bioavailability enhancer | US 5, 744, 161 | BioPerine® | |
| Use of piperine to increase bioavailability of nutritional compounds | US 5, 536, 506 | BioPerine® |
| Sl. No. | Title | Patent No | Brand /Ingredient |
|---|---|---|---|
| Hair care compositions containing extracellular metabolite preparation from Bacillus coagulans | Australia AU2018282020 |
LactoSporin® | |
| Modulation of immune function by Bacillus coagulans | Australia AU2019262918 |
Immunospore | |
| Fructophilic lactic acid producing bacteria | Australia AU2019445706 |
Fructospore | |
| Composition for prostaglandin transporter inhibition and related therapeutic applications | Australia AU2019449279 |
Hypertension Formulation | |
| Aphrodisiac composition and management of male sexual dysfunction | Australia AU2019430124 |
Withanalpha™ | |
| Adaptogenic compositions and applications thereof | Australia AU2016393811 |
Boswellin® PS + Saberry® / Cococin® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Australia AU2016358297 |
LactoSpore® | |
| Composition containing Oroxylin A and method of extraction thereof | Australia AU2017356883 |
Sabroxy® | |
| Skin care compositions and their applications | Australia AU2019249392 |
Ethyl ascorbic acid + THC | |
| Liver protectant composition and therapeutic applications | Australia AU2019240210 |
LivLonga® | |
| Compositions for the management of hyperglycemia and related conditions | Australia AU2018397668 |
Nigellin® | |
| Spent turmeric- methods and compositions thereof | Australia AU2018307222 |
Starmeric® | |
| Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna | Australia AU2018290219 |
Arjuna | |
| Skin care applications of extracellular metabolites from Bacillus coagulans | Australia AU2018282067 |
LactoSporin® | |
| Compositions for management of Helicobacter pylori infections | Australia AU2018281141 |
LactoSpore® + Saberry® | |
| Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa | Australia AU2006235807 |
Curcumin C3 Reduct® | |
| Compositions containing thymohydroquinone and their method of preparation | Australia AU2018397667 |
Nigellin® | |
| Alcoholic beverage composition containing Bacillus coagulans | Australia AU2018337853 |
LactoSpore® | |
| Compositions and methods for reducing flatulence | Australia AU2018282018 |
LactoSpore® | |
| Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 | Australia AU2018282252 |
LactoSporin® | |
| Enzyme composition for therapeutic management of muscle soreness | Australia AU2016428484 |
DigeZyme® | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Australia AU2016413572 |
LactoSpore® | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Australia AU2015394033 |
Cyperus | |
| Oleanoyl peptide compositions and collagen enhancement | Australia AU2015381703 |
Olepent® | |
| Bioavailable composition of natural and synthetic HCA | Australia AU773081 |
GarCitrin® | |
| Compositions and methods for the management of hyperproliferative dermatological conditions | Australia AU2004322710 |
Boswellin® | |
| Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation | Australia AU2006321973 |
SelenoForce® | |
| Process for preparing water soluble diterpenes and their applications | Australia AU2004272005 |
Ocufors® | |
| Anti-obesity potential of Calebin A | Australia AU2012366253 |
CurCousin® | |
| Hepatoprotectant activity of garcinol | Australia AU2011352073 |
Livinol™ | |
| Composition for down-regulating pro-inflammatory markers | Australia AU2011200854 |
Boswellin® PS | |
| Protective compositions for dermal papilla cells | Australia AU2010326651 |
Saberry® + Cococin™ | |
| Oleanoyl peptide composition and a method of treating skin aging | Australia AU2011265587 |
Olepent® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Australia AU2014369819 |
LactoSporin® | |
| Method for the treatment of hypercholesterolemia | Australia AU2014202312 |
CurCousin® | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | Australia AU2012203148 |
Saberry® + Cococin™+ Se Peptide | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Australia AU2015308650 |
LactoSpore® | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Australia AU2013292593 |
Cyperus | |
| Composition and method for the protection of articular cartilage | Australia AU2014201769 |
CurCousin® | |
| Anti-obesity potential of Calebin A | Australia AU2014203122 |
CurCousin® | |
| Process and compositions for achieving mammalian energy balance | Australia AU2015351423 |
Forskolin | |
| Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl) butadiene | Australia AU2016385393 |
Zingiber cassumnar | |
| Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | Australia AU2018335280 |
LactoSporin® | |
| Synthesis of Calebin A and its biologically active analogs | Australia AU2014203764 |
CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Australia AU2017228561 |
LactoSporin® | |
| Compositions containing thymohydroquinone and their method of preparation | Brasil BR 11 2020 012333-1 |
Nigellin® | |
| Aphrodisiac composition and management of male sexual dysfunction |
Brasil BR 11 2020 025686-2 |
WithanAlpha™ | |
| Skin care compositions and their applications |
Brasil BR 11 2020 020445-5 |
Ethyl Ascorbic Acid + SabiWhite® | |
| Curcuminoid composition and its therapuetic potential in managing lung fibrosis | Canada CA3153877 |
C3 Reduct® Special | |
| Plant actives and their anti-pollution effects thereof | Canada CA3152792 |
Sabroxy® + (THC / Pterostilbene / Artonox®) | |
| Liver protectant composition and therapeutic applications | Canada CA3094625 |
LivLonga® | |
| Compositions for microbial anti-adhesion | Canada CA3083777 |
Lactocran™ | |
| Hypolipidemic effects of Bacillus coagulans | Canada CA3065162 |
LactoSpore® | |
| Compositions containing thymohydroquinone and their method of preparation | Canada CA3087050 |
Nigellin® | |
| Compositions for the management of hyperglycemia and related conditions | Canada CA3087042 |
Nigellin® | |
| Process for the preparation of standardized composition of from the bark of Terminalia arjuna | Canada CA3066772 |
Arjuna | |
| Neuroprotective compositions and their use | Canada CA3063757 |
Sabroxy® | |
| Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | Canada CA3075635 |
Oletrip® | |
| Compositions for management of Helicobacter pylori infections | Canada CA3061613 |
LactoSpore® + Saberry® | |
| Spent turmeric - Methods and compositions thereof | Canada CA3071190 |
Starmeric® | |
| Compositions for reducing trimethylamine-n-oxide and related therapeutic applications | Canada CA3076739 |
Pterostilbene | |
| Skin care applications of extracellular metabolites fromBacillus coagulans | Canada CA3065334 |
LactoSporin® | |
| Composition and methods for beta secretase inhibition | Canada CA3063751 |
Sabroxy® | |
| Alcoholic beverage composition containing Bacillus coagulans | Canada CA3075642 |
LactoSpore® | |
| Anti-pollution compositions containing Bacillus coagulans | Canada CA3074267 |
LactoSpore® | |
| Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 | Canada CA3064939 |
LactoSporin® | |
| Adaptogenic compositions and applications thereof | Canada CA3014238 |
Boswellin® PS + Saberry® / Cococin™ | |
| Use of piperine as a bioavailability enhancer | Canada CA2247467 |
BioPerine® | |
| Forskolin for promoting lean body mass | Canada CA2281562 |
ForsLean® | |
| Novel method for extraction of Oxyresveratrol from Artocarpus hirsutus | Canada CA3047702 |
Artocarpus hirsutus | |
| Composition containing Oroxylin A and method of extraction thereof | Canada CA3043168 |
Sabroxy® | |
| Natural molecules from Artocarpus hirsutus: Method of isolation and anti-acne potential thereof | Canada CA3047701 |
Artocarpus hirsutus | |
| Bacillus coagulans MTCC 5856 For The Management Of Major Depressive Disorder | Canada CA3023818 |
LactoSpore® | |
| Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | Canada CA2999517 |
LactoSpore® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Canada CA2967952 |
LactoSpore® | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Canada CA2883176 |
Cyperus | |
| Process for preparing water-soluble medicaments comprising complexation of forskolin in cyclodextrins | Canada CA2537820 |
Ocufors® | |
| Anti-obesity Potential of Calebin A | Canada CA2857543 |
CurCousin® | |
| Composition for down-regulating pro-inflammatory markers | Canada CA2732915 |
Boswellin® PS | |
| Hepatoprotectant activity of garcinol | Canada CA2851663 |
Livinol™ | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | Canada CA2872535 |
Saberry® + Cococin™+ Se Peptide | |
| Method for the treatment of hypercholesterolemia | Canada CA2850999 |
CurCousin® | |
| Synthesis of Calebin A and its biologically active analogs | Canada CA2858126 |
CurCousin® | |
| Calebin A for hepatic steatosis | Canada CA2893321 |
CurCousin® | |
| Composition and method for the protection of articular cartilage | Canada CA2935898 |
CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Canada CA2899511 |
LactoSporin®, LactoSporin® + SabiLize® |
|
| Method for the treatment of hypercholesterolemia | Canada CA2963383 |
CurCousin® | |
| Calebin A for osteoporosis | Canada CA2941050 |
CurCousin® | |
| Oleanoyl peptide composition and collagen enhancement | Canada CA2975170 |
Olepent® | |
| Method to solubilize curcuminoids in water | Canada CA2976689 |
uC3 CLEAR® | |
| Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | Canada CA2979287 |
Zingiber cassumnar | |
| Method for the treatment of hypercholesterolemia | Taiwan I622384 |
CurCousin® | |
| Composition for down-regulating pro-inflammatory markers | Taiwan I-434696 |
Boswellin® PS | |
| Method of enhancing the viable counts of lactic acid bacteria and method of producing short chain fatty acids | Vietnam VN33287 |
LactoSpore® | |
| Method of solubilising forskolin and isoforskolin in water and clear aqueous solution comprising the same | Vietnam 12717 |
Ocufors® | |
| Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | Germany DE10196213 |
Cosmoperine® | |
| Liver protectant compositions and therapeutic applications | Hong kong HK40045252 |
LivLonga® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 5856 | Hong kong HK1240122 |
LactoSpore® | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Hong kong HK1232483 |
Cyperus | |
| Process and compositions for achieving mammalian energy balance | Hong kong HK1238675 |
Forskolin | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Hong kong HK1233174 |
LactoSpore® | |
| Synthesis of Calebin A and its biologically active analogs | Hong kong HK1217689 |
CurCousin® | |
| Process for preparing water soluble diterpenes and their applications | Hong kong HK1098450 |
Ocufors® | |
| Method for the treatment of hypercholesterolemia | Hong kong HK1210590 |
CurCousin® | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | Hong kong HK1193758 |
Saberry®+ Cococin™ + Se Peptide | |
| Calebin A for articular cartilage | Hong kong HK1210028 |
CurCousin® | |
| Calebin A for use in the treatment of Inflammation and obesity | Hong kong HK1190874 |
CurCousin® | |
| Compositions for managing chronic obstructive pulmonary disease | China ZL 202180015345.2 |
Curucmin BD3 Complex | |
| Plant actives and their anti-pollution effects thereof | China ZL202080072290.4 |
Sabroxy® + (THC / Pterostilbene / Resvenox®) | |
| Enzyme composition for therapeutic management of muscle soreness | China ZL201680090576.9 |
DigeZyme® | |
| Compositions for the management of hyperglycemia and related conditions | China ZL201880083854.7 |
Nigellin® | |
| Compositions containing thymohydroquinone and their method of preparation | China ZL201880083853.2 |
Nigellin® | |
| Composition containing Oroxylin A and method of extraction thereof | China ZL201780070049.6 |
Sabroxy® | |
| Process and compositions for achieving mammalian energy balance | China ZL201580083933.4 |
Forskolin | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | China ZL201680008035.7 |
LactoSpore® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | China ZL201580042813.X |
LactoSpore® | |
| Process For Preparing Water Soluble Diterpenes And Their Applications | China ZL200480028804.7 |
Ocufors® | |
| Compositions and methods for the management of hyperproliferative dermatological conditions | China ZL200480043675.9 |
Boswellin® | |
| Anti-obesity potential of Calebin A | China ZL201280012577.3 |
CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | China ZL201480010615.0 |
LactoSporin®, LactoSporin® + SabiLize® |
|
| Melanogenesis inhibition by 3,5-dimethoxy-4'-hydroxypterostilbenes and cosmeceutical applications thereof | DPR Korea 1011504 |
pTeroWhite® | |
| Composition containing Oroxylin A and method of extraction thereof | Europe EP3538089 |
Oroxylin | |
| Composition and methods for beta secretase inhibition | Europe EP3638277 |
Sabroxy® | |
| Alcoholic beverage composition containing Bacillus coagulans | Europe EP3684900 |
LactoSpore® | |
| Liver protectant compositions and therapeutic applications | Europe EP3768237 |
LivLonga® | |
| Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 | Europe EP3634375 |
Artocarpus | |
| Natural molecules from Artocarpus hirsutus: method of isolation and anti-acne potential thereof | Europe EP3558958 |
Artocarpus | |
| Compositions for management of Helicobacter pylori infections | Europe EP3634444 |
LactoSpore® + Saberry® | |
| Stable probiotic composition containing Bacillus coagulans MTCC 5856 and method of detection thereof | Europe EP3544620 |
LactoSpore® | |
| Oleanoyl peptide composition and collagen enhancement | Europe EP3253400 |
Olepent® | |
| Novel method for extraction of Oxyresveratrol from Artocarpus hirsutus | Europe EP3558283 |
Artocarpus hirsutus | |
| Use of piperine as a bioavailability enhancer | Europe EP0810868 |
BioPerine® | |
| Bioprotectant composition, method of use and extraction process of curcuminoids | Europe EP0839037 |
Curcumin C3 Complex® | |
| Forskolin for promoting lean body mass | Europe EP0977564 |
ForsLean® | |
| Neuroprotective compositions and their use | Europe EP3638278 |
Sabroxy® | |
| Enzyme composition for therapeutic management of muscle soreness | Europe EP3534934 |
DigeZyme® | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Europe EP3478304 |
LactoSpore® | |
| Adaptogenic compositions and applications thereof | Europe EP3419640 |
Polybos | |
| Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | Europe EP3356545 |
LactoSpore® | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Europe EP3291805 |
Cyperus | |
| Coconut water and its method of preparation | Europe EP1341547 |
Cococin™ | |
| Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells | Europe EP1328263 |
Curcumin C3 Reduct® | |
| Bioavailable composition of natural and synthetic HCA | Europe EP1254209 |
Garcitrin® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Europe EP3240553 |
LactoSpore® | |
| Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa | Europe EP1171144 |
Curcumin C3 Reduct® | |
| Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation | Europe EP1968620 |
SelenoForce® | |
| Process for preparing water soluble diterpenes and their applications | Europe EP1718568 |
Ocufors® | |
| Compositions and methods for the management of hyperproliferative dermatological conditions | Europe EP1791423 |
Boswellin® | |
| Hepatoprotectant activity of garcinol | Europe EP2658374 |
Livinol™ | |
| Protective compositions for dermal papilla cells | Europe EP2461786 |
Saberry® + Cococin™ | |
| Method for the treatment of hypercholesterolemia | Europe EP2937084 |
CurCousin® | |
| Calebin A for use in the treatment of inflammation and obesity | Europe EP2663185 |
CurCousin® | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | Europe EP2695603 |
Saberry® + Cococin™ + Se Peptide | |
| Composition and method for the protection of articular cartilage | Europe EP2893926 |
CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Europe EP2989197 |
LactoSporin® | |
| Calebin A for inducing lipolysis | Europe EP3085370 |
CurCousin® | |
| Synthesis of Calebin A and its biologically active analogs | Europe EP2963007 |
CurCousin® | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Europe EP2744571 |
Cyperus | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Europe EP3108935 |
Cyperus | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Europe EP3185877 |
LactoSpore® | |
| Process and composition for achieving mammalian energy balance | Europe EP3194575 |
Forskolin | |
| Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | India IN514647 |
Oletrip | |
| Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna | India IN484255 |
Arjuna | |
| Skin care compositions and their applications | India IN356811 |
Ethyl Asccorbic acid + Sabiwhite® | |
| A method for solubilizing forskolin and a composition thereof | India IN235492 |
Ocufors® | |
| A Process of preparing a synergistic composition for treating hyperproliferative dermatological condition | India IN238950 |
Boswellin® | |
| A process for obtaining high purity fatty alcohols | India IN229695 |
Policosanol | |
| Fructophilic lactic acid producing bacteria | Japan JP7469332 |
Fructospore | |
| Liver protectant composition and therapeutic applications | Japan JP7411564 |
LivLonga® | |
| Method and composition for therapeutic management of gluten intolerance | Japan JP7390398 |
LactoSpore® + DigeZyme® | |
| Composition for prostaglandin transporter inhibition and related therapeutic applications | Japan JP7335360 |
Hypertension Formulation | |
| Anti-pollution compositions containing Bacillus coagulans | Japan JP7262445 |
LactoSpore® | |
| Spent turmeric - methods and compositions thereof | Japan JP7209691 |
Starmeric® | |
| Hypolipidemic effects of Bacillus coagulans | Japan JP7220677 |
LactoSpore® | |
| Adaptogenic compositions and applications thereof | Japan JP7220565 |
Boswellin® PS + Saberry® / Cococin® | |
| Composition and methods for beta secretase inhibition | Japan JP7209645 |
Sabroxy® | |
| Modulation of immune function by Bacillus coagulans | Japan JP7183301 |
Immunospore | |
| Hair care compositions containing extracellular metabolite preparation from bacillus coagulans | Japan JP7150753 |
LactoSporin® | |
| Alcoholic beverage composition containing Bacillus coagulans | Japan JP7135079 |
LactoSpore® | |
| Compositions containing thymohydroquinone and their method of preparation | Japan JP7089033 |
Nigellin® | |
| Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna | Japan JP7083215 |
Arjuna | |
| Beverage compositions containing Bacillus coagulans MTCC 5856 | Japan JP7076148 |
LactoSpore® | |
| Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 | Japan JP7039626 |
LactoSporin® | |
| Compositions for the management of hyperglycemia and related conditions | Japan JP7012857 |
Nigellin® | |
| Compositions and methods for reducing flatulence | Japan JP6987888 |
LactoSpore® | |
| Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | Japan JP6979518 |
Oletrip | |
| Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | Japan JP6938479 |
LactoSpore® | |
| Use of Piperine as a bioavailability enhancer | Japan JP3953513 |
BioPerine® | |
| Novel method for extraction of Oxyresveratrol from Artocarpus hirsutus | Japan JP6920462 |
Artocarpus hirsutus | |
| Skin care applications of extracellular metabolites from Bacillus coagulans | Japan JP6918988 |
LactoSporin® | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Japan JP6908633 |
LactoSpore® | |
| Natural molecules from Artocarpus hirsutus: Method of isolation and anti-acne potential thereof | Japan JP6896885 |
Artocarpus hirsutus | |
| Enzyme composition for therapeutic management of muscle soreness | Japan JP6857240 |
DigeZyme® | |
| Composition containing Oroxylin A and method of extraction thereof | Japan JP6851476 |
Sabroxy® | |
| Composition for management of Helicobacter pylori infection | Japan JP6839329 |
LactoSpore® + Saberry® | |
| Neuroprotective compositions and their use | Japan JP6796217 |
Sabroxy® | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Japan JP6759243 |
Cyperus | |
| Process of obtaining compositions of stable Lutein and Lutein derivatives | Japan JP4227409 |
Xenogard® | |
| Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | Japan JP4098985 |
Cosmoperine® | |
| Bio-available compositions of natural and synthetic HCA | Japan JP4205943 |
GarCitrin® | |
| Compositions and methods for the management of hyper-proliferative dermatological conditions | Japan JP4820819 |
Boswellin® | |
| Process for preparing water soluble diterpenes and their applications | Japan JP5021305 |
Ocufors® | |
| Hepatoprotectant activity of garcinol | Japan JP5980228 |
Livinol™ | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | Japan JP6064274 |
Saberry® + Cococin™ + Se Peptide | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Japan JP6126307 |
LactoSporin®, LactoSporin® + SabiLize® |
|
| Scirpusin A and Scirpusin B and anti-obesity potential thereof | Japan JP6135761 |
Cyperus | |
| Composition and method for the protection of articular cartilage | Japan JP6142446 |
CurCousin® | |
| Calebin A for hepatic steatosis | Japan JP6336943 |
CurCousin® | |
| Oleanoyl peptide composition and a method of treating skin aging | Japan JP6176893 |
Olepent® | |
| Method for the treatment of hypercholesterolemia | Japan JP6263707 |
CurCousin® | |
| Anti-obesity potential of Calebin A | Japan JP6374716 |
CurCousin® | |
| Process and compositions for achieving mammalian energy balance | Japan JP6472453 |
Forskolin | |
| Synthesis of Calebin A and its biologically active analogs | Japan JP6490927 |
CurCousin® | |
| Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | Japan JP6584526 |
Zingiber cassumnar | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Japan JP6629875 |
LactoSpore® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Japan JP6630723 |
LactoSpore® | |
| Enzyme composition for its use in the therapeutic treatment of delayed onset muscular soreness | Mexico MX397674 |
DigeZyme® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Mexico MX384468 |
LactoSpore® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Mexico MX389328 |
Forskolin | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Mexico MX376004 |
LactoSpore® | |
| Process for preparing water soluble diterpenes and their applications | Mexico MX260326 |
Ocufors® | |
| Composition for down-regulating pro-inflammatory markers | Mexico MX328842 |
Boswellin® PS | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | Mexico MX355546 |
Saberry® + Cococin™ +Se Peptide | |
| Enzyme composition for therapeutic management of muscle soreness | Malaysia MY-198090-A |
DigeZyme® | |
| Adaptogenic compositions and applications thereof | Malaysia MY-189911-A |
Polybos | |
| Process and compositions for achieving mammalian energy balance | Malaysia MY-188869-A |
Forskolin | |
| Oleanoyl peptide composition and collagen enhancement | Malaysia MY-188723-A |
Olepent® | |
| Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | Malaysia MY-185340-A |
LactoSpore® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Malaysia MY-182658-A |
LactoSpore® | |
| Calebin A for hepatic steatosis | Malaysia MY-182000-A |
CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Malaysia MY-181102-A |
LactoSporin® | |
| Compositions and method for the protection of articular cartilage | Malaysia MY-175867-A |
CurCousin® | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | Malaysia MY-168089-A |
Saberry® + Cococin™ +Se Peptide | |
| Method for the treatment of hypercholesterolemia | Malaysia MY-170067-A |
CurCousin® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Malaysia MY-174855-A |
LactoSpore® | |
| Hypolipidemic effects of Bacillus coagulans | New Zealand NZ760204 |
LactoSpore® | |
| Beverage compositions containing Bacillus coagulans MTCC 5856 | New Zealand NZ758787 |
LactoSpore® | |
| Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna | New Zealand NZ760781 |
Arjuna | |
| Compositions and methods for reducing flatulence | New Zealand NZ759306 |
LactoSpore® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | New Zealand NZ732234 |
LactoSpore® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | New Zealand NZ748360 |
LactoSpore® | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder | New Zealand NZ748553 |
LactoSpore® | |
| Composition containing Oroxylin A and method of extraction thereof | New Zealand NZ753943 |
Sabroxy® | |
| Enzyme composition for therapeutic management of muscle soreness | New Zealand NZ752952 |
DigeZyme® | |
| Composition for physiological increase of male and female hormones with diterpene forskolin and its derivatives | New Zealand NZ552997 |
Forskolin | |
| Compositions and methods for the management of hyperproliferative dermatological conditions | New Zealand NZ552027 |
Boswellin® | |
| Commercial process for making forskolin and its derivatives | New Zealand NZ568652 |
Ocufors® | |
| Process for preparing water soluble diterpenes and their applications | New Zealand NZ545765 |
Ocufors® | |
| Bioavailable composition of natural and synthetic HCA | New Zealand NZ518116 |
GarCitrin® | |
| Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa | New Zealand NZ514884 |
Curcumin C3 Reduct® | |
| Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation | New Zealand NZ568233 |
SelenoForce® | |
| Protective compositions for dermal papilla cells | New Zealand NZ598630 |
Saberry®+ Cococin™ | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | New Zealand NZ600307 |
Saberry®+ Cococin™ + Se dipeptide | |
| Method for the treatment of hypercholesterolemia | New Zealand NZ624269 |
CurCousin® | |
| Hepatoprotectant activity of garcinol | New Zealand NZ609878 |
Livinol™ | |
| Anti-obesity potential of Calebin A | New Zealand NZ614076 |
CurCousin® | |
| Synthesis of Calebin A and its biologically active analogs | New Zealand NZ627247 |
CurCousin® | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | New Zealand NZ622927 |
Cyperus | |
| Anti-obesity potential of calebin A | New Zealand NZ715053 |
CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | New Zealand NZ711345 |
LactoSporin®, LactoSporin® + SabiLize® |
|
| Composition and method for the protection of articular cartilage | New Zealand NZ622909 |
CurCousin® | |
| Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | New Zealand NZ735027 |
Zingiber cassumnar | |
| Method to solubilize curcuminoids in water | New Zealand NZ734491 |
UC3 clear® | |
| Process and compositions for achieving mammalian energy balance | New Zealand NZ720422 |
Forskolin | |
| Anti-pollution compositions containing Bacillus coagulans | Russia RU2745755 |
LactoSpore® | |
| Process for the isolation of novel glycosides from Pterocarpus marsupium and their therapeutic effects | Russia RU2799555 |
pTeroSol® | |
| Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | Russia RU2733372 |
Oletrip | |
| Compositions and methods for the management of hyperproliferative dermatological conditions | Russia RU2366412 |
Boswellin® | |
| Anti-obesity potential of Calebin A | Russia RU2543334 |
CurCousin® | |
| Hepatoprotectant activity of garcinol | Russia RU2585245 |
Livinol™ | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | Russia RU2606752 |
Saberry® + Cococin™ + Se Peptide | |
| Calebin A for hepatic steatosis | Russia RU2643297 |
CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Russia RU2617965 |
LactoSporin®, LactoSporin® + SabiLize® |
|
| Calebin A for osteoporosis | Russia RU2653103 |
CurCousin® | |
| Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | Russia RU2694053 |
Zingiber cassumnar | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Russia RU2691404 |
Cyperus | |
| Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | Singapore SG11201707112P |
Zingiber cassumnar | |
| Enzyme composition for therapeutic management of muscle soreness | Singapore SG11201903791R |
DigeZyme® | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Singapore SG11201809841Q |
LactoSpore® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Singapore SG11201706099Q |
LactoSpore® | |
| Process and compositions for achieving mammalian energy balance | Singapore SG11201801873T |
Forskolin | |
| Process for preparing water soluble diterpenes and their applications | Singapore SG121197 |
Ocufors® | |
| Compositions and methods for the management of hyperproliferative dermatological conditions | Singapore SG136165 |
Boswellin® | |
| Calebin A for hepatic steatosis | Singapore SG10201503805X |
CurCousin® | |
| Composition and methods for the protection of articular cartilage | Singapore SG11201605336Y |
CurCousin® | |
| Anti-obesity potential of calebin A | Singapore SG192695 |
CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Singapore SG11201505628P |
LactoSporin®, LactoSporin® + SabiLize® |
|
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Singapore SG11201700006U |
LactoSpore® | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Singapore SG11201707106U |
Cyperus | |
| Composition for prostaglandin transporter inhibition and related therapeutic applications | South Africa ZA2022/00266 |
Hypertension Formulation | |
| Fructophilic lactic acid producing bacteria |
South Africa ZA2021/10214 |
Fructospore | |
| Aphrodisiac composition and management of male sexual dysfunction |
South Africa ZA2020/07819 |
Withanalpha™ | |
| Compositions containing thymohydroquinone and their method of preparation |
South Africa ZA2020/04531 |
Nigellin® | |
| Liver protectant composition and therapeutic applications |
South Africa ZA2020/06540 |
LivLonga® | |
| Modulation of immune function by Bacillus coagulans |
South Africa ZA2020/07348 |
Immunospore | |
| Skin care compositions and their applications |
South Africa ZA2020/06708 |
Ethyl Ascorbic Acid + SabiWhite® | |
| Compositions for the management of hyperglycemia and related conditions |
South Africa ZA2020/04532 |
Nigellin® | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder |
South Africa ZA2019/00501 |
LactoSpore® | |
| Enzyme composition for maintenance of metabolic health | South Africa 2019/07676 |
DigeZyme® | |
| Composition and methods for the management of hyperproliferative dermatological Conditions | South Africa ZA2007/0694 |
Boswellin® | |
| Process for preparing water soluble diterpenes and their applications |
South Africa ZA2006/01898 |
Ocufors® | |
| Anti-obesity potential of Calebin A |
South Africa ZA2013/05918 |
CurCousin® | |
| Method to solubilize curcuminoids in water |
South Africa ZA2017/06503 |
UC3 Clear® | |
| Enzyme composition for therapeutic management of muscle soreness |
South Africa ZA2019/02715 |
DigeZyme® | |
| Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | Great Britain GB2380675 |
Cosmoperine® | |
| Process for preparing water soluble diterpenes and their application | Uzbekistan 4028 |
Ocufors® | |
| Method and composition for therapeutic management of gluten intolerance | Eurasia EA048069 |
LactoSpore® | |
| Compositions for the management of hyperglycemia and related conditions | Eurasia EA047210 |
Nigellin® | |
| Alcoholic beverage composition containing Bacillus coagulans | Eurasia EA045649 |
LactoSpore® | |
| Compositions containing thymohydroquinone and their method of preparation | Eurasia EA045642 |
Nigellin® | |
| Skin care compositions and their applications | Eurasia EA045810 |
Ethyl Asccorbic acid + Sabiwhite® | |
| Liver protectant composition and therapeutic applications | Eurasia EA045555 |
LivLonga® | |
| Enzyme composition for therapeutic management of muscle soreness | Eurasia EA044794 |
DigeZyme® | |
| Aphrodisiac Composition And Management Of Male Sexual Dysfunction | Eurasia EA044487 |
Withanalpha™ | |
| Process and composition for achieving mammalian energy balance | Eurasia EA38685 |
Forskolin | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 5856 | Eurasia EA037312 |
LactoSpore® | |
| Process for preparing water soluble diterpenes and their applications | Eurasia EA012836 |
Ocufors® | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Eurasia EA038255 |
LactoSpore® | |
| Protective compositions for dermal papilla cells | Eurasia EA20368 |
Saberry® + Cococin™ | |
| Use of a composition for down-regulating/inhibiting PGE2 | Eurasia EA023717 |
Boswellin® PS | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Eurasia EA025578 |
Cyperus | |
| Method for the treatment of hypercholesterolemia | Eurasia EA027148 |
CurCousin® | |
| Use of calebin A to protect mammalian articular cartilage from pathological damage | Eurasia EA027614 |
CurCousin® | |
| Synthesis of calebin A and its biologically active analogs | Eurasia EA027726 |
CurCousin® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Eurasia EA034017 |
LactoSpore® | |
| Oleanoyl peptide composition and collagen enhancement | Eurasia EA035128 |
Olepent® | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder |
Philippines PH1-2018-502419 |
LactoSpore® | |
| Oleanoyl peptide composition and collagen enhancement |
Philippines PH1-2017-501234 |
Olepent® | |
| Adaptogenic compositions and applications thereof |
Philippines PH1-2018-501607 |
Boswellin® PS + Saberry® / Cococin® | |
| Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene |
Philippines PH1-2017-501663 |
Zingiber cassumunar | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 |
Philippines PH1-2017-50132 |
LactoSpore® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof |
Philippines PH1-2017-500059 |
LactoSpore® | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof |
Philippines PH1-2015-500349 |
Cyperus | |
| Process for preparing water soluble diterpenes and their applications |
Philippines PH1-2006-500481 |
Ocufors® | |
| Method for the treatment of hypercholesterolemia |
Philippines PH1-2014-000244 |
CurCousin® | |
| Calebin A for hepatic steatosis |
Philippines PH1-2015-000188 |
CurCousin® | |
| Composition and method for the protection of articular cartilage |
Philippines PH1-2016-501138 |
CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof |
Philippines PH1-2015-502025 |
LactoSporin®, LactoSporin® + SabiLize® |
|
| Method and composition for therapeutic management of gluten intolerance |
Republic of Korea KR10-2684843 |
LactoSpore® | |
| Beverage compositions containing Bacillus coagulans MTCC 5856 |
Republic of Korea KR10-2648066 |
LactoSpore® | |
| Compositions for the management of hyperglycemia and related conditions |
Republic of Korea KR10-2577863 |
Nigellin® | |
| Aphrodisiac composition and management of male sexual dysfunction |
Republic of Korea KR10-2571381 |
Withanalpha™ | |
| Modulation of immune function by Bacillus coagulans |
Republic of Korea KR10-2558669 |
Immunospore™ | |
| Compositions containing thymohydroquinone and their method of preparation |
Republic of Korea KR10-2539298 |
Nigellin® | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder |
Republic of Korea KR10-2533865 |
LactoSpore® | |
| Alcoholic beverage composition containing Bacillus coagulans |
Republic of Korea KR10-2515209 |
LactoSpore® | |
| Liver protectant compositions and therapeutic applications |
Republic of Korea KR10-2498126 |
LivLonga® | |
| Compositions and methods for reducing flatulence |
Republic of Korea KR10-2452792 |
LactoSpore® | |
| Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof |
Republic of Korea KR10-2412222 |
Oletrip | |
| Compositions for management of Helicobacter pylori infections |
Republic of Korea KR10-2403453 |
LactoSpore® + Saberry® | |
| Anti-pollution compositions containing Bacillus coagulans |
Republic of Korea KR10-2376076 |
LactoSpore® | |
| Skin care applications of extracellular metabolites from Bacillus coagulans |
Republic of Korea KR10-2296051 |
LactoSporin® | |
| Anti-obesity potential of garcinol |
Republic of Korea KR10-2289324 |
Garcinol | |
| Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 |
Republic of Korea KR10-2288904 |
LactoSporin® | |
| Hair care compositions containing extracellular metabolite preparation from Bacillus coagulans |
Republic of Korea KR10-2288897 |
LactoSporin® | |
| Process and compositions for achieving mammalian energy balance |
Republic of Korea KR10-2169620 |
Forskolin | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 5856 |
Republic of Korea KR10-2157043 |
LactoSpore® | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof |
Republic of Korea KR10-1600212 |
Cyperus | |
| Synthesis of Calebin A and its biologically active analogs |
Republic of Korea KR10-1629561 |
CurCousin® | |
| Method for the treatment of hypercholesterolemia |
Republic of Korea KR10-1647549 |
CurCousin® | |
| Composition and method for the protection of articular cartilage |
Republic of Korea KR10-1685263 |
CurCousin® | |
| Composition and method for the protection of articular cartilage |
Republic of Korea KR10-1685333 |
CurCousin® | |
| Anti-obesity potential of Calebin A |
Republic of Korea KR10-1702702 |
CurCousin® | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof |
Republic of Korea KR10-1717889 |
Cyperus | |
| Calebin A for hepatic steatosis |
Republic of Korea KR10-1763474 |
CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof |
Republic of Korea KR 10-1770902 |
LactoSporin®, LactoSporin® + SabiLize® |
|
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof |
Republic of Korea KR10-2089566 |
LactoSpore® | |
| Aphrodisiac composition and management of male sexual dysfunction | Indonesia IDP000093473 |
WithanAlpha™ | |
| Enzyme composition for therapeutic management of muscle soreness | Indonesia IDP000089633 |
DigeZyme® | |
| Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna | Indonesia IDP000085113 |
Arjuna | |
| Oleanoyl peptide composition and collagen enhancement | Indonesia IDP000074771 |
Olepent® | |
| Novel pcr primers and methods thereof for the identification of Bacillus coagulans | Indonesia IDP000074645 |
LactoSpore® | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Indonesia IDP000074062 |
Cyperus | |
| Process and compositions for achieving mammalian energy balance | Indonesia IDP000071226 |
ForsLean® | |
| Calebin A for hepatic steatosis | Indonesia IDP000067993 |
CurCousin® | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cell | Indonesia IDP000051688 |
Saberry® + Cococin™ + Se-dipeptide | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Indonesia IDP00201506134 |
LactoSporin®, LactoSporin® + SabiLize® |
|
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Indonesia IDP000062703 |
Cyperus | |
| Calebin A and its effect on hypercholesterolemia | Indonesia IDP000064827 |
CurCousin® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Indonesia IDP000066793 |
LactoSpore® | |
| Adaptogenic compositions and applications thereof | Indonesia IDP000088019 |
Boswellin® PS + Saberry® / Cococin | |
| Compositions and methods for the management of hyperproliferative dermatological conditions |
United Arab Emirates AE3178 |
Boswellin® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | United Arab Emirates AE6288 |
LactoSpore® |
- Active
- Expired
503 Great Patents
- Australia45
- Brasil2
- Canada43
- China13
- DPR Korea1
- Eurasia20
- Europe40
- Germany1
- Great Britain1
- Hong Kong11
- India6
- Indonesia14
- Japan49
- Malaysia12
- Mexico7
- New Zealand29
- Philippines12
- Republic of Korea29
- Russia12
- Singapore13
- South Africa15
- Taiwan2
- UAE2
- USA120
- Uzbekistan1
- Vietnam2